Athanase Innovation AB (ATIN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Athanase Innovation AB (ATIN) has a cash flow conversion efficiency ratio of -0.077x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-31.25 Million ≈ $-3.36 Million USD) by net assets (Skr405.72 Million ≈ $43.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Athanase Innovation AB for the company's overall valuation and market capitalisation.
Athanase Innovation AB - Cash Flow Conversion Efficiency Trend (2018–2026)
This chart illustrates how Athanase Innovation AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Athanase Innovation AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Athanase Innovation AB ranked by their cash flow conversion efficiency. Explore Athanase Innovation AB cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sachem Capital Corp
NYSE MKT:SACH
|
-0.017x |
|
Daehan New Pharm Co. Ltd
KQ:054670
|
0.034x |
|
Gihon Telekomunikasi Indonesia Tbk PT
JK:GHON
|
0.046x |
|
Energia Latina SA
SN:ENLASA
|
0.077x |
|
International Conveyors Limited
NSE:INTLCONV
|
-0.015x |
|
Hansol Csn
KO:009180
|
0.030x |
|
Somnomed Ltd
AU:SOM
|
0.083x |
|
Acrivon Therapeutics, Inc. Common Stock
NASDAQ:ACRV
|
-0.096x |
Annual Cash Flow Conversion Efficiency for Athanase Innovation AB (2018–2026)
The table below shows the annual cash flow conversion efficiency of Athanase Innovation AB from 2018 to 2026. View Athanase Innovation AB stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-06-30 | Skr427.41 Million ≈ $46.00 Million |
Skr-65.63 Million ≈ $-7.06 Million |
-0.154x | -397.70% |
| 2025-06-30 | Skr484.76 Million ≈ $52.17 Million |
Skr-14.96 Million ≈ $-1.61 Million |
-0.031x | +76.54% |
| 2024-06-30 | Skr634.09 Million ≈ $68.24 Million |
Skr-83.40 Million ≈ $-8.98 Million |
-0.132x | -138.64% |
| 2023-06-30 | Skr791.89 Million ≈ $85.22 Million |
Skr-43.65 Million ≈ $-4.70 Million |
-0.055x | -235.90% |
| 2022-06-30 | Skr907.40 Million ≈ $97.65 Million |
Skr-14.89 Million ≈ $-1.60 Million |
-0.016x | -100.27% |
| 2021-06-30 | Skr3.73 Million ≈ $401.95K |
Skr23.10 Million ≈ $2.49 Million |
6.185x | +6656.90% |
| 2020-06-30 | Skr244.06 Million ≈ $26.26 Million |
Skr22.34 Million ≈ $2.40 Million |
0.092x | -16.01% |
| 2019-06-30 | Skr260.43 Million ≈ $28.03 Million |
Skr28.38 Million ≈ $3.05 Million |
0.109x | +100.30% |
| 2018-06-30 | Skr276.69 Million ≈ $29.78 Million |
Skr15.05 Million ≈ $1.62 Million |
0.054x | -- |
About Athanase Innovation AB
Athanase Innovation AB is public venture capital firm specializing in seed funding. The firm primarily invests in private and public technology and innovation companies. It also develops and sells machine inspection unit, used for automatic quality control, inspection and measurement of pallets. The firm typically invests in companies in US and Nordic markets. Athanase Innovation AB was founded i… Read more